Sweden · Delayed Price · Currency is SEK Volati AB Earnings Call Transcripts
Fiscal Year 2026
-
Quarterly results showed 11% sales growth but weaker EBITA due to challenges in S:t Eriks and Tornum, while Communication and Ettiketto performed well. Strong cash flow supported three acquisitions and the separate listing of Salix Group.
-
Net sales rose 3% year-over-year, with adjusted EBITDA up 4% after excluding non-recurring listing costs. Salix Group delivered 37% organic EBITDA growth, and two acquisitions added SEK 930 million in turnover. Cost measures and a strong acquisition pipeline position the group for future growth.
Fiscal Year 2025
-
Q4 saw flat sales but a 3% EBITDA increase, led by Salix’s 74% EBITDA growth. Full-year results were driven by acquisitions, with organic growth stabilizing and strong cash conversion. The group is preparing Salix for a potential listing and expects continued improvement in 2026.
-
Organic growth returned with 9% sales and 11% EBITDA growth, led by Salix Group's strong quarter. Margin pressure in Etiketto and mixed results in Industry reflect ongoing market challenges. A potential Salix Group spin-off is under evaluation.
-
Net sales rose 6% and EBITDA matched last year, with strong growth in Solix and Etiquette offset by Industry weakness. Acquisition activity remains robust, and cash flow is set to strengthen in H2, positioning the group for further growth as markets recover.
-
Q1 delivered strong sales and EBITDA growth, driven by both organic improvements and acquisitions, despite ongoing market uncertainty. Platforms are well-positioned for further recovery, with strategic acquisitions and expanded credit facilities supporting future growth.
Fiscal Year 2024
-
Q4 delivered 11% sales growth and a return to organic growth across all business areas, with strong cash flow enabling continued acquisitions. Margins held up despite market headwinds, and the group is positioned for accelerated growth as markets recover.
-
Q3 results matched last year, with 4% revenue growth and stable margins despite weak markets. Ettiketto Group excelled with 15% organic growth, while Salix and Corroventa performed solidly. Market recovery is expected in 2025, supporting future growth.
-
Q2 results showed stable sales and EBITDA despite market headwinds, with strong cash flow and continued acquisition momentum. Segment performance was mixed, but margin improvements and a robust pipeline position the company well for future growth.